Korenberg Matthew E

CIK 00016499034 companiesWAYNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001649903

Recent Transactions

50 trades

Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2025-07-15+19,506→ 44,060 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Non-Qualified Stock Option (right to buy)
2025-02-05+123,559→ 123,559 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Incentive Stock Option (right to buy)
2025-02-05+5,373→ 5,373 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Option (right to buy)
2024-12-13+167,100→ 167,100 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-23$100.05/sh−2,481→ 58,068 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-23$102.05/sh−201→ 50,777 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-23$101.61/sh−7,090→ 50,978 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-23$49.99/sh+395→ 51,172 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2024-09-23−9,377→ 42,436 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-23$52.84/sh+9,377→ 60,549 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2024-09-23−395→ 0 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-20$104.10/sh−6,275→ 50,777 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-20$49.99/sh+4,982→ 57,052 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2024-09-20−4,982→ 395 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-16$58.49/sh+849→ 50,788 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2024-09-16−3,340→ 18,500 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-16$105.00/sh−1,938→ 52,070 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2024-09-16−849→ 12,452 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2024-09-16−914→ 25,949 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-16$105.00/sh−472→ 50,316 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2024-09-16−671→ 5,377 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-16$60.94/sh+3,340→ 54,008 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-16$105.00/sh−319→ 50,668 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-16$55.75/sh+914→ 50,424 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-16$49.99/sh+671→ 50,987 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-09-16$105.00/sh−485→ 49,939 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-08-26$106.32/sh−5,212→ 49,510 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-08-26$105.02/sh−6,177→ 54,722 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-08-23$105.13/sh−4,275→ 60,899 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-08-23$104.09/sh−2,037→ 65,174 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-08-22$105.54/sh−1,157→ 67,211 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2024-08-19+24,554→ 24,554 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-08-09$98.50/sh−18,245→ 68,368 total
Other
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-06-28$60.71/sh+350→ 86,613 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-05-14$85.68/sh−520→ 86,263 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-05-14$85.08/sh−13,638→ 86,783 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-05-13$84.54/sh−3,440→ 100,421 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-02-27+14,416→ 103,861 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2024-02-27+58,544→ 58,544 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-02-15$74.65/sh−4,778→ 89,445 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-01-02$72.31/sh−2,917→ 94,223 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-12-05$59.61/sh−1,984→ 97,140 total
Other
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-06-30$56.78/sh+376→ 99,124 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-02-23+9,069→ 98,748 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2023-02-23+24,628→ 24,628 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-02-15$72.98/sh−2,890→ 89,679 total
Tax Payment
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2022-12-28$66.29/sh−3,859→ 92,569 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2022-12-22+25,967→ 25,967 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2022-12-13+14,000→ 96,428 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Employee Stock Option (right to buy)
2022-12-13+30,000→ 30,000 total

Companies

Recent Filings

Address

C/O PALVELLA THERAPEUTICS, INC. 125 STRAFFORD AVENUE, SUITE 360

WAYNE, PA, 19087

View on SEC.gov